Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
12.97(c) 13.13(c) 13.83(c) 14.48(c) 14.33(c) Last
102 085 86 249 99 917 171 867 259 007 Volume
+0.39% +1.23% +5.33% +4.70% -1.04% Change
More quotes
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets.The company operates its business through two segments: Therapeutics and Biosurgery segment.The... 
More about the company
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 58,4 M
EBIT 2014 0,68 M
Net income 2014 -3,35 M
Debt 2014 -
Yield 2014 -
Sales 2015 82,2 M
EBIT 2015 8,40 M
Net income 2015 -0,38 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 8,42x
Capi. / Sales 2015 5,99x
Capitalization 492 M
More Financials
Latest news on OSIRIS THERAPEUTICS, INC.
12/08 OSIRIS THERAPEUTICS : Appoints New Executives to Team
12/04 OSIRIS THERAPEUTICS : Announces Expansion of the Leadership Team
12/03 OSIRIS THERAPEUTICS : Announces Expansion of the Leadership Team
12/01 OSIRIS THERAPEUTICS : to Present at the 26th Annual Piper Jaffray Healthcare Con..
11/26 OSIRIS THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
11/19 OSIRIS THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
11/17 OSIRIS THERAPEUTICS : to Present at the Canaccord Genuity Medical Technology and..
11/12 OSIRIS THERAPEUTICS : Releases 3rd Quarter 2014 Financial Results
More news
Sector news
3h ago MEDIVATION : takes up $335m Curetech licensing option
2d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
2d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF